MIND insider award — 50,000 options, $8.64 strike, vesting to 2028
Rhea-AI Filing Summary
Insider option grant to CFO: The chief financial officer, Mark Alan Cox, received an award of 50,000 stock options to purchase common stock at an exercise price of $8.64. The options were granted on 10/06/2025, become exercisable on the grant date with an expiration date of 10/06/2035, and vest in three equal annual installments: one-third on 10/06/2026, one-third on 10/06/2027, and one-third on 10/06/2028.
The filing was submitted by a single reporting person in the role of CFO. After the grant, the reporting person beneficially owns 50,000 underlying shares via the option award. The form is informational about insider compensation and does not include additional financial results or other corporate actions.
Positive
- Retention-focused vesting: Options vest in three equal installments (one-third annually) which supports executive retention through 10/06/2028.
- Long exercise window: Ten-year term (10/06/2035) provides flexibility for alignment with long-term stock performance.
Negative
- Potential future dilution: 50,000 underlying shares could dilute existing shareholders if exercised before offsetting share reductions.
- Value dependent on stock performance: Exercise price of $8.64 means award yields value only if market price exceeds that level before expiration.
Insights
50,000 options align pay with long-term shareholder value over a 10-year term.
The grant of 50,000 options at an exercise price of $8.64 creates a ten-year window (10/06/2035) for value realization and ties eventual payout to future stock performance. The graded vesting (one-third annually starting 10/06/2026) encourages retention across three years.
This structure reduces immediate dilution risk but creates potential future dilution if options are exercised; monitor outstanding option counts and total share count in upcoming reports to assess shareholder impact over the next 3 years.
Standard Section 16 disclosure; timing and vesting are explicit and routine.
The Form 4 records a standard, documented equity award to an officer with clear vesting milestones and an exercise price equal to the grant value. Filing by an attorney-in-fact and the included vesting schedule meet disclosure norms.
Investors may note the exercise price $8.64 relative to market price at grant; if market is below the price, the award is retention-focused rather than immediate compensation. Watch for related filings showing exercises or additional grants within 12 months.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Option to Purchase Common Stock | 50,000 | $8.64 | $432K |
Footnotes (1)
- [object Object]